AN

Amburose Nirmalprabu

Active Director Managing Director DIN 10564397
DIN 10564397 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Amburose Nirmalprabu

Data last updated:

Amburose Nirmalprabu is a Managing Director at Accelio Labs Private Limited (since 2024).

DIN 10564397
Primary Designation Managing Director
First Appointment 26 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Accelio Labs Private Limited U86905TZ2024PTC031053
Managing Director26 Mar 20242024Active

Board colleagues of Amburose Nirmalprabu

NameDINCompanyDesignation
Dhanapal Parthiban10564398Accelio Labs Private LimitedDirector
Nallaramadoss Senthilkumar11064552Accelio Labs Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Accelio Labs Private Limited
Premium access

Shareholding and investment profile for Amburose Nirmalprabu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amburose Nirmalprabu

Amburose Nirmalprabu currently holds 1 directorship: Accelio Labs Private Limited (Managing Director, since 26 Mar 2024).

Amburose Nirmalprabu was first appointed on 26 Mar 2024 as Managing Director at Accelio Labs Private Limited.

The current boards of Amburose Nirmalprabu's companies include Dhanapal Parthiban (Accelio Labs Private Limited), Nallaramadoss Senthilkumar (Accelio Labs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available